Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India.
- DOI
- 10.1007/s10792-026-04321-2
- Published
- 2026 Oct 28
- Container
- International ophthalmology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10792-026-04321-2,
title = {Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India.},
author = {Hareendran H and Menon A and Shenoy PK and Rajan ND and Shoaib Nawaz and Krishnan MPA},
year = {2026},
journal = {International ophthalmology},
doi = {10.1007/s10792-026-04321-2},
url = {https://doi.org/10.1007/s10792-026-04321-2}
}RIS
TY - JOUR TI - Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India. AU - Hareendran H AU - Menon A AU - Shenoy PK AU - Rajan ND AU - Shoaib Nawaz AU - Krishnan MPA PY - 2026 JO - International ophthalmology DO - 10.1007/s10792-026-04321-2 UR - https://doi.org/10.1007/s10792-026-04321-2 ER -
APA
H, H., A, M., PK, S., ND, R., Nawaz, S., & MPA, K. (2026). Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India.. International ophthalmology. https://doi.org/10.1007/s10792-026-04321-2
Source records
- pubmed · retrieved 2026-11-10T12:25:40.345Z